Shehnaaz Suliman
Director/Board Member bij ULTRAGENYX PHARMACEUTICAL INC.
Vermogen: 866 593 $ op 31-03-2024
Actieve functies van Shehnaaz Suliman
| Bedrijven | Functie | Begin | Einde |
|---|---|---|---|
| ULTRAGENYX PHARMACEUTICAL INC. | Director/Board Member | 30-01-2019 | - |
| Independent Dir/Board Member | 30-01-2019 | - | |
| 10X GENOMICS, INC. | Director/Board Member | 01-08-2019 | - |
| Independent Dir/Board Member | 01-08-2019 | - | |
Executive Women in Bio
 Executive Women in Bio Miscellaneous Commercial ServicesCommercial Services Executive Women in Bio provides mentoring program services to support women in various stages of career and personal development. | Chairman | - | - |
ReCode Therapeutics, Inc.
 ReCode Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology ReCode Therapeutics, Inc. operates as a biopharmaceutical company. It develops precision medicines for pulmonary diseases. The company is headquartered in Irvin, TX. | Director/Board Member | 11-01-2022 | - |
| Chief Executive Officer | 11-01-2022 | - |
Loopbaan van Shehnaaz Suliman
Eerdere bekende functies van Shehnaaz Suliman
| Bedrijven | Functie | Begin | Einde |
|---|---|---|---|
| ALECTOR, INC. | Chief Executive Officer | 11-12-2019 | 15-12-2021 |
| Chief Operating Officer | 11-12-2019 | 01-01-2022 | |
| President | 11-12-2019 | 15-12-2021 | |
Parvus Therapeutics, Inc.
 Parvus Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Parvus Therapeutics, Inc. manufactures and sells biopharmaceutical products. The private company is based in Calgary, Canada. | Director/Board Member | 01-10-2017 | 01-07-2019 |
| THERAVANCE BIOPHARMA, INC. | Corporate Officer/Principal | 01-07-2017 | 31-03-2019 |
| ROCHE HOLDING AG | Corporate Officer/Principal | 01-06-2015 | 01-07-2017 |
Opleiding van Shehnaaz Suliman
| University of Oxford | Graduate Degree |
| University of Cape Town | Doctorate Degree |
| Saïd Business School | Masters Business Admin |
Statistieken
Internationaal
| Verenigde Staten | 7 |
| Verenigd Koninkrijk | 3 |
| Zwitserland | 2 |
Operationeel
| Director/Board Member | 4 |
| Corporate Officer/Principal | 2 |
| Masters Business Admin | 2 |
Sectoraal
| Health Technology | 8 |
| Consumer Services | 4 |
| Commercial Services | 2 |
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Verwante bedrijven
| Beursgenoteerde bedrijven | 5 |
|---|---|
| ROCHE HOLDING AG | Health Technology |
| ULTRAGENYX PHARMACEUTICAL INC. | Health Technology |
| 10X GENOMICS, INC. | Health Technology |
| THERAVANCE BIOPHARMA, INC. | Health Technology |
| ALECTOR, INC. | Health Technology |
| Bedrijven in privébezit | 3 |
|---|---|
ReCode Therapeutics, Inc.
ReCode Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology ReCode Therapeutics, Inc. operates as a biopharmaceutical company. It develops precision medicines for pulmonary diseases. The company is headquartered in Irvin, TX. | Health Technology |
Parvus Therapeutics, Inc.
Parvus Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Parvus Therapeutics, Inc. manufactures and sells biopharmaceutical products. The private company is based in Calgary, Canada. | Health Technology |
Executive Women in Bio
Executive Women in Bio Miscellaneous Commercial ServicesCommercial Services Executive Women in Bio provides mentoring program services to support women in various stages of career and personal development. | Commercial Services |
- Beurs
- Insiders
- Shehnaaz Suliman
- Ervaring
